TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36105938

Group type: EXPERIMENTAL
Intervention: Comprehensive strength training intervention (CST)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 123
Study: 34836278

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 (PS128) treatment (LT) - 2 capsules (3 × 10^10 CFU/capsule) each morning and evening for 4 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo treatment (PT) - 2 capsules for 4 weeks
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 (PS128) treatment (LT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo treatment (PT)
Number of subjects: 8
Study: 32280123

Group type: EXPERIMENTAL
Intervention: HPV self-sampling
Number of subjects: 2

Group type: COMPARATOR
Intervention: Navigation to Pap smear
Number of subjects: 2

Group type: COMPARATOR
Intervention: Standard cervical cancer screening education
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: HPV self-sampling delivered in-person
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: HPV self-sampling delivered via mail
Number of subjects: 2
Study: 36219046

Group type: EXPERIMENTAL
Intervention: Tapinarof cream 1% QD for 21 days
Number of subjects: 376

Group type: COMPARATOR
Intervention: Vehicle or other appropriate controls
Number of subjects: 376
Study: 32003872

Group type: EXPERIMENTAL
Intervention: Short implants (6 mm)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Long implants (10 mm)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Crown-to-implant ratio
Number of subjects: 96
Study: 34375789

Group type: EXPERIMENTAL
Intervention: vortioxetine with celecoxib
Number of subjects: 0

Group type: COMPARATOR
Intervention: vortioxetine with placebo
Number of subjects: 0
Study: 34265015

Group type: EXPERIMENTAL
Intervention: POCUS‐SPA
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: BC
Number of subjects: 114

Group type: COMPARATOR
Intervention: SPA
Number of subjects: 114
Study: 33408691

Group type: EXPERIMENTAL
Intervention: Oligopin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Maltodextrin (placebo)
Number of subjects: 80
Study: 33296620

Group type: EXPERIMENTAL
Intervention: nGVS
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 36
Study: 34262113

Group type: EXPERIMENTAL
Intervention: Cold atmospheric plasma treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham control treatment
Number of subjects: 22
Study: 35596633

Group type: EXPERIMENTAL
Intervention: Iso-calorie diet + Food for Special Dietary Use (FSDU) (2 portions per day for 14 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Iso-calorie diet (ICD) alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Iso-calorie diet + FSDU
Number of subjects: 20
Study: 33298342

Group type: EXPERIMENTAL
Intervention: Chemotherapy treatment regimens modified to reduce toxicity in older/senior patients; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Geriatric assessments to select older patients for rigorous treatment regimens; specific assessment methods not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Broadened clinical trial inclusion criteria for older/senior patients; specific criteria not mentioned.
Number of subjects: 0
Study: 34302956

Group type: EXPERIMENTAL
Intervention: Hyperacute neuropathic pain assessment using DN4 within the first 5 days post-injury
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Late presenting neuropathic pain
Number of subjects: 78
Study: 33780665

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 668
Study: 35578722

Group type: EXPERIMENTAL
Intervention: Family participatory nursing model based on WeChat platform
Number of subjects: 100
Study: 33711216

Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) levels in T2DM cases
Number of subjects: 60

Group type: COMPARATOR
Intervention: Interleukin-2 (IL-2) levels in non-diabetic controls
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Interleukin-18 (IL-18) levels in T2DM cases
Number of subjects: 60

Group type: COMPARATOR
Intervention: Interleukin-18 (IL-18) levels in non-diabetic controls
Number of subjects: 60
Study: 32559735

Group type: EXPERIMENTAL
Intervention: 3-month self- and family management support programs
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study: 36295645

Group type: EXPERIMENTAL
Intervention: Perineal massage by a specialized physiotherapist
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Self-applied perineal massage
Number of subjects: 81

Group type: COMPARATOR
Intervention: Ordinary obstetric care (Control)
Number of subjects: 81
Study: 32701199

Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg once daily (3 weeks on, 1 week off)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 48
Study: 35935309

Group type: EXPERIMENTAL
Intervention: DEX 1.0 ug/kg
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: DEX 0.8 ug/kg
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: DEX 0.5 ug/kg
Number of subjects: 97

Group type: COMPARATOR
Intervention: 0.9% NaCl solution 10 mL (Control)
Number of subjects: 97
Study: 34180425

Group type: EXPERIMENTAL
Intervention: SSC exercise program plus physical rehabilitation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard physical rehabilitation
Number of subjects: 42
Study: 32991582

Group type: EXPERIMENTAL
Intervention: Dynamic Tape (DT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Kinesio Tape (KT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No tape (Control)
Number of subjects: 45
Study: 36086735

Group type: EXPERIMENTAL
Intervention: Semi-customized exercises including dynamic thoracic mobility, trunk stabilization exercises, and static stretching during warm-up.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 70
Study: 33909358

Group type: EXPERIMENTAL
Intervention: Rehabilitation robot rehabilitation training synchronizing acupuncture exercise therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Acupuncture exercise therapy (Control)
Number of subjects: 50
Study: 36007871

Group type: EXPERIMENTAL
Intervention: Late evening snack and oral amino acid capsules (LES and OAA)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Late evening snack (LES)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 34018290

Group type: EXPERIMENTAL
Intervention: 0.05 mmol/kg gadobenate
Number of subjects: 352

Group type: COMPARATOR
Intervention: 0.1 mmol/kg gadobenate
Number of subjects: 352
Study: 33068346

Group type: EXPERIMENTAL
Intervention: Acupuncture of 'Zhibian (BL 54) through Shuidao (ST 28)'
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non‐permeable sham acupuncture at Zhibian (BL 54)
Number of subjects: 90
Study: 34042156

Group type: EXPERIMENTAL
Intervention: Upadacitinib
Number of subjects: 74

Group type: COMPARATOR
Intervention: Anti-TNF
Number of subjects: 74
Study: 32011196

Group type: EXPERIMENTAL
Intervention: A-PRP injections
Number of subjects: 90

Group type: COMPARATOR
Intervention: AA-PRP injections
Number of subjects: 90
Study: 34882161

Group type: EXPERIMENTAL
Intervention: Healthy dietary pattern (HDP) only
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Healthy dietary pattern (HDP) with 15 g day-1 wolfberries
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (HDP only)
Number of subjects: 24
Study: 32947492

Group type: EXPERIMENTAL
Intervention: Single cycle of canalith repositioning procedure (CRP)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Multiple cycles of canalith repositioning procedure (CRP)
Number of subjects: 143
Study: 32282342

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 19546

Group type: COMPARATOR
Intervention: Annual FIT
Number of subjects: 19546

Group type: EXPERIMENTAL
Intervention: Annual risk-adapted screening
Number of subjects: 19546
Study: 33664334

Group type: EXPERIMENTAL
Intervention: Aquatic exercise (AE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Burdock root extract (BE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 0
Study: 34086393

Group type: EXPERIMENTAL
Intervention: On-clamp RAPN
Number of subjects: 324

Group type: COMPARATOR
Intervention: Off-clamp RAPN
Number of subjects: 324
Study: 33545793

Group type: EXPERIMENTAL
Intervention: Assist/control (A/C) group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation (PSV) group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Weaning index (WI) < 50.44
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Weaning index (WI) < 61.45 in A/C group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Weaning index (WI) < 51.45 in PSV group
Number of subjects: 40
Study: 34825898

Group type: EXPERIMENTAL
Intervention: Dronabinol (5-15 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 34348539

Group type: EXPERIMENTAL
Intervention: VC-Free model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VCI model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UNI model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo arm of VITALITY-ALS clinical trial
Number of subjects: 0
Study: 36451771

Group type: EXPERIMENTAL
Intervention: Ramucirumab
Number of subjects: 7410

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7410
Study: 32068255

Group type: EXPERIMENTAL
Intervention: Original bortezomib dosing regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less frequent bortezomib dosing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm of the ALCYONE clinical trial
Number of subjects: 0
Study: 36426618

Group type: EXPERIMENTAL
Intervention: Automated VR cognitive behavior therapy (VR‐CBT) app treatment (n = 77)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Wait-list control condition (n = 76)
Number of subjects: 153
Study: 33415649

Group type: EXPERIMENTAL
Intervention: Telehealth self-management, shared care intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32497553

Group type: EXPERIMENTAL
Intervention: Calcium silicate and sodium phosphate toothpaste (CSSP)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Fluoride control toothpaste
Number of subjects: 247
Study: 35259172

Group type: EXPERIMENTAL
Intervention: Responsive Caregiving Intervention
Number of subjects: 39

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 39
Study: 36175320

Group type: EXPERIMENTAL
Intervention: Restorative neurostimulation
Number of subjects: 204
Study: 33934973

Group type: EXPERIMENTAL
Intervention: Active coping strategies
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Passive coping strategies
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Presence of neuropathic pain
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Baseline VISA-A score
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Overall outcome
Number of subjects: 80
Study: 32891018

Group type: EXPERIMENTAL
Intervention: Multimodal balance training with rhythmical auditory stimuli (RAS-supported intervention, n = 17)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Multimodal balance training without rhythmical auditory cues (n = 18)
Number of subjects: 35
Study: 36377369

Group type: EXPERIMENTAL
Intervention: HOPE intervention (social media groups with peer leaders)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (social media groups without peer leaders)
Number of subjects: 300
Study: 34016257

Group type: EXPERIMENTAL
Intervention: First appropriate ICD shock
Number of subjects: 5516

Group type: EXPERIMENTAL
Intervention: Inappropriate shock
Number of subjects: 5516

Group type: EXPERIMENTAL
Intervention: ICD therapy for VT ≥200 beats/min or VF
Number of subjects: 5516

Group type: EXPERIMENTAL
Intervention: Appropriate therapy for VT <200 beats/min or inappropriate therapy
Number of subjects: 5516

Group type: EXPERIMENTAL
Intervention: Combined assessment of all therapy and arrhythmia types
Number of subjects: 5516

Group type: EXPERIMENTAL
Intervention: 2 or more ICD appropriate shocks
Number of subjects: 5516
Study: 32856073

Group type: EXPERIMENTAL
Intervention: Follicular flushing (5 flushes)
Number of subjects: 164
Study: 35640009

Group type: EXPERIMENTAL
Intervention: Pain educational video
Number of subjects: 77

Group type: COMPARATOR
Intervention: No video (control group)
Number of subjects: 77
Study: 32217042

Group type: EXPERIMENTAL
Intervention: Pop music
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Rock music
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Western Classical music
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Persian Traditional music
Number of subjects: 46

Group type: COMPARATOR
Intervention: Silence
Number of subjects: 46
Study: 36347196

Group type: EXPERIMENTAL
Intervention: VENT strategy (low-tidal-volume with positive end-expiratory pressure)
Number of subjects: 725

Group type: COMPARATOR
Intervention: noV strategy (resting-lung strategy, no ventilation)
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: VENT strategy
Number of subjects: 725
Study: 33120301

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg kg−1 IV
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg kg−1 IV and Magnesium 2 g IV
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 36380280

Group type: EXPERIMENTAL
Intervention: Combination of OK lens and 0.01% atropine eye drops
Number of subjects: 60

Group type: COMPARATOR
Intervention: Combination of OK lens and placebo
Number of subjects: 60
Study: 35777876

Group type: EXPERIMENTAL
Intervention: Clinician-focused intervention including explicit elicitation of parental concerns, a prognostic algorithm to identify low-risk children, and provision of safety-netting advice printout.
Number of subjects: 336496

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned in the abstract.
Number of subjects: 336496
Study: 34006604

Group type: COMPARATOR
Intervention: Mailed letter about HCV screening (letter only)
Number of subjects: 21303

Group type: EXPERIMENTAL
Intervention: Mailed letter with laboratory order for HCV screening (letter+order)
Number of subjects: 21303

Group type: COMPARATOR
Intervention: Usual care content
Number of subjects: 21303

Group type: EXPERIMENTAL
Intervention: Behavioral science content
Number of subjects: 21303

Group type: EXPERIMENTAL
Intervention: Mailed letter about HCV screening (for active patient portal users)
Number of subjects: 21303

Group type: COMPARATOR
Intervention: Patient portal message with similar content (for active patient portal users)
Number of subjects: 21303
Study: 32171426

Group type: EXPERIMENTAL
Intervention: Pertuzumab, trastuzumab, and docetaxel
Number of subjects: 808

Group type: COMPARATOR
Intervention: Placebo, trastuzumab, and docetaxel
Number of subjects: 808
Study: 32388627

Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment in groups (MBT-G)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 111
Study: 32308550

Group type: EXPERIMENTAL
Intervention: Figure‐of‐8‐Suture
Number of subjects: 290

Group type: COMPARATOR
Intervention: Manual compression (control group)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Figure‐of‐8‐Suture (in obese patients)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Manual compression (control group, in obese patients)
Number of subjects: 290
Study: 33568144

Group type: EXPERIMENTAL
Intervention: Persian version of the celiac disease quality of life questionnaire (PCDQOL)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: PCDQOL compared with SF36 and self-rated QOL
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Internal consistency and test-retest reliability of PCDQOL
Number of subjects: 220
Study: 33410736

Group type: EXPERIMENTAL
Intervention: Z-drugs
Number of subjects: 6809

Group type: COMPARATOR
Intervention: Control (no Z-drugs)
Number of subjects: 6809
Study: 32439979

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 616

Group type: COMPARATOR
Intervention: Dasatinib
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Imatinib (female patients)
Number of subjects: 616
Study: 34410749

Group type: EXPERIMENTAL
Intervention: Tailored Metacognitive Reflection and Insight Therapy (MERIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Metacognitive Reflection and Insight Therapy (MERIT)
Number of subjects: 0
Study: 34815011

Group type: EXPERIMENTAL
Intervention: Psychoeducational pain self-management intervention (6-week duration, including education, skills building, and nurse coaching)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nurse support during the intervention
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Qualitative learning experiences post-RCT
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Data integration of quantitative and qualitative findings
Number of subjects: 28
Study: 32375328

Group type: EXPERIMENTAL
Intervention: Low-frequency group (LF group) doing two longer interval sessions per week
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-frequency group (HF group) doing four short interval sessions per week
Number of subjects: 15
Study: 35618372

Group type: EXPERIMENTAL
Intervention: Behavior Support Coaching for Paraprofessional Model (BSC-P)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 259
Study: 34841124

Group type: EXPERIMENTAL
Intervention: Pelvic floor physical therapy (PFPT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Postponed treatment of PFPT (Control)
Number of subjects: 140
Study: 32423255

Group type: EXPERIMENTAL
Intervention: Fruit Smoothie (FS)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cereal and Milk (CM)
Number of subjects: 25
Study: 32436173

Group type: COMPARATOR
Intervention: SRP + saline (Group 1)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: SRP + HA gel (Group 2)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: SRP + HA mouth rinse (Group 3)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: SRP + HA mouth rinse + HA gingival gel (Group 4)
Number of subjects: 96
Study: 35168289

Group type: EXPERIMENTAL
Intervention: MSCs in fibrin (1 million cells/cm2 of wound bed surface)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Fibrin spray alone
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 11
Study: 33632136

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting early isolated distal deep vein thrombosis (IDDVT)
Number of subjects: 647
Study: 35060116

Group type: EXPERIMENTAL
Intervention: Daily aroma (sweet orange essential oil)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Aroma every other day (sweet orange essential oil)
Number of subjects: 109

Group type: COMPARATOR
Intervention: No aroma (control)
Number of subjects: 109
Study: 33496829

Group type: EXPERIMENTAL
Intervention: Combined deep learning model
Number of subjects: 384

Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 384

Group type: COMPARATOR
Intervention: DL image model
Number of subjects: 384

Group type: COMPARATOR
Intervention: BI-RADS approach
Number of subjects: 384

Group type: COMPARATOR
Intervention: Combined deep learning model vs senior radiologists
Number of subjects: 384

Group type: COMPARATOR
Intervention: Combined deep learning model vs junior radiologists
Number of subjects: 384

Group type: COMPARATOR
Intervention: AI assistance for junior radiologists
Number of subjects: 384

Group type: COMPARATOR
Intervention: Interobserver agreement
Number of subjects: 384
Study: 34836700

Group type: EXPERIMENTAL
Intervention: ER10 (light-curing for 10 s)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ER40 (light-curing for 40 s)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: SE10 (light-curing for 10 s)
Number of subjects: 35
Study: 32169321

Group type: EXPERIMENTAL
Intervention: Eyelid warming mask (EWM) applied for 30 min before bedtime daily for 4 weeks
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Artificial tears administered as a single-use every day as needed for 4 weeks
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group maintained normal lifestyle without treatment
Number of subjects: 81
Study: 32460460

Group type: EXPERIMENTAL
Intervention: Entecavir plus tenofovir (ETV+TDF), n=45
Number of subjects: 91

Group type: COMPARATOR
Intervention: Lamivudine/telbivudine plus adefovir (LAM/LdT+ADV), n=46
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 91
Study: 35986390

Group type: EXPERIMENTAL
Intervention: FX06 (2 × 200 mg per day) administered intravenously for 5 consecutive days
Number of subjects: 306

Group type: COMPARATOR
Intervention: Placebo administered intravenously for 5 consecutive days
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: FX06
Number of subjects: 306
Study: 34319506

Group type: EXPERIMENTAL
Intervention: True acupuncture with electro-acupuncture (EA) for 16 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham acupuncture for 16 weeks
Number of subjects: 54
Study: 32131082

Group type: EXPERIMENTAL
Intervention: Early exercise regimes
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control (no early exercise regimes)
Number of subjects: 115
Study: 33875631

Group type: EXPERIMENTAL
Intervention: hsa_circ_0021739 overexpression
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: hsa_circ_0021739 expression
Number of subjects: 53
Study: 33218566

Group type: EXPERIMENTAL
Intervention: Pilates training for 8 weeks (three sessions of 60 min)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no Pilates training)
Number of subjects: 19
Study: 36087611

Group type: EXPERIMENTAL
Intervention: Vilobelimab (800 mg intravenously for a maximum of six doses on days 1, 2, 4, 8, 15, and 22)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Placebo (matching placebo with standard of care)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Vilobelimab (in predefined analysis without site-stratification)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Vilobelimab
Number of subjects: 368
Study: 33215600

Group type: EXPERIMENTAL
Intervention: Adjuvant anthracycline-taxane-based chemotherapy followed by endocrine therapy
Number of subjects: 241